相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CpG oligodeoxynucleotide-based therapy of lymphoid malignancies
George J. Weiner
ADVANCED DRUG DELIVERY REVIEWS (2009)
Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity
Shin-ichiro Fujii et al.
BLOOD (2009)
Identification of regulatory T cells during experimental Leishmania infantum infection
Olivia Roos Rodrigues et al.
IMMUNOBIOLOGY (2009)
DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice
Sami Ben Hadj Ahmed et al.
VACCINE (2009)
New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2008)
An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection
Cindy Allenbach et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Recent developments in leishmaniasis vaccine delivery systems
Sudipta Bhowmick et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Regulatory T cells as therapeutic target in Hodgkin's lymphoma
Christian Koenecke et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Leishmaniasis treatment - a challenge that remains: a review
Dilvani O. Santos et al.
PARASITOLOGY RESEARCH (2008)
Immunology - Neutrophil soldiers or Trojan horses?
Beena John et al.
SCIENCE (2008)
In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies
Nathan C. Peters et al.
SCIENCE (2008)
Immunochemotherapy of persistent post-kata-azar dermal leishmaniasis: a novel approach to treatment
Ahmed Mudawi Musa et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C
Dendev Batdelger et al.
VACCINE (2008)
LIGHT is critical for IL-12 production by dendritic cells, optimal CD4+ th1 cell response, and resistance to leishmania major
Guilian Xu et al.
JOURNAL OF IMMUNOLOGY (2007)
Immune response to leishmania: paradox rather than paradigm
Parul Tripathi et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
Lymphotoxin αβ2 (Membrane lymphotoxin) is critically important for resistance to Leishmania major infection in mice
Guilian Xu et al.
JOURNAL OF IMMUNOLOGY (2007)
Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune® vaccine
F. N. Santos et al.
VACCINE (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate
Paola Andrea Barroso et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Balancing immunity and pathology in visceral leishmaniasis
Amanda C. Stanley et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Exposure to Leishmania major modulates the proportion of CD4+T cells without affecting cellular immune responses
Mohammad Hossein Alimohammadian et al.
MICROBIOLOGY AND IMMUNOLOGY (2007)
Oral miltefosine for the treatment of Indian visceral leishmaniasis
Shyam Sundar et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Immunotherapy for drug-refractory mucosal leishmaniasis
Roberto Badaro et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy
Manish Bodas et al.
JOURNAL OF IMMUNOLOGY (2006)
Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani
R. Gamboa-Leon et al.
VACCINE (2006)
Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis
S Sundar et al.
CLINICAL INFECTIOUS DISEASES (2006)
Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity
F Woelbing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Drug resistance in leishmaniasis
SL Croft et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment
W Mayrink et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2006)
Treatment options for visceral leish maniasis: a systematic review of clinical studies done in India, 1980-2004
PL Olliaro et al.
LANCET INFECTIOUS DISEASES (2005)
Control of infection with Leishmania major in susceptible BALB/c mice lacking the common γ-chain for FcR is associated with reduced production of IL-10 and TGF-β by parasitized cells
UM Padigel et al.
JOURNAL OF IMMUNOLOGY (2005)
Interleukin 10 receptor blockade - pentavalent antimony treatment in experimental visceral leishmaniasis
HW Murray
ACTA TROPICA (2005)
Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran
F Iraji et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2005)
Amphotericin B treatment for Indian visceral leishmaniasis: Conventional versus lipid formulations
S Sundar et al.
CLINICAL INFECTIOUS DISEASES (2004)
Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and Bacillus Calmette-Guerin -: Preliminary report
J Convit et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2004)
The immunopathology of experimental visceral leishmaniasis
PM Kaye et al.
IMMUNOLOGICAL REVIEWS (2004)
Leishmaniasis: current situation and new perspectives
P Desjeux
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2004)
Cutting edge:: Neutrophil granulocyte serves as a vector for Leishmania entry into macrophages
G van Zandbergen et al.
JOURNAL OF IMMUNOLOGY (2004)
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis
RX Armijos et al.
ACTA TROPICA (2004)
Current treatment approaches to leishmaniasis
J Berman
CURRENT OPINION IN INFECTIOUS DISEASES (2003)
The role of CD4+CD25+ regulatory T cells in Leishmania infection
Y Belkaid
EXPERT OPINION ON BIOLOGICAL THERAPY (2003)
Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis
HW Murray et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Immunotherapy of American cutaneous leishmaniasis in Venezuela during the period 1990-99
J Convit et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2003)
Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine
WR Santos et al.
VACCINE (2003)
Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate
G Faghihi et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2003)
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
Y Belkaid et al.
NATURE (2002)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A role for tumor necrosis factor-α in remodeling the splenic marginal zone during Leishmania donovani infection
CR Engwerda et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major
E Aga et al.
JOURNAL OF IMMUNOLOGY (2002)
The role of IL-12 in maintaining resistance to Leishmania major
AY Park et al.
JOURNAL OF IMMUNOLOGY (2002)
Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection
I Follador et al.
CLINICAL INFECTIOUS DISEASES (2002)
Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors
H Laufs et al.
INFECTION AND IMMUNITY (2002)
Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala
BA Arana et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
Clinical and experimental advances in treatment of visceral leishmaniasis
HW Murray
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble leishmania antigen in human cutaneous leishmaniasis
RLA Bottrel et al.
INFECTION AND IMMUNITY (2001)
The role of IL-10 in promoting disease progression in leishmaniasis
MM Kane et al.
JOURNAL OF IMMUNOLOGY (2001)
Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection
MM Gicheru et al.
INFECTION AND IMMUNITY (2001)
IL-12 is required to maintain a Th1 response during Leishmania major infection
AY Park et al.
JOURNAL OF IMMUNOLOGY (2000)
Therapy of murine cutaneous leishmaniasis by DNA vaccination
E Handman et al.
VACCINE (2000)
InBALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease
H Himmelrich et al.
JOURNAL OF IMMUNOLOGY (2000)
Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection
S Ajdary et al.
INFECTION AND IMMUNITY (2000)
Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms
HW Murray et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Organ-specific immune responses associated with infectious disease
CR Engwerda et al.
IMMUNOLOGY TODAY (2000)
Dendritic cell regulation of T(H)1-T(H)2 development
M Moser et al.
NATURE IMMUNOLOGY (2000)
分享论文
